Uric acid predicts clinical outcomes in heart failure - Insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology

被引:138
作者
Hare, JM
Johnson, RJ
机构
[1] Johns Hopkins Univ Hosp, Sch Med, Div Cardiol, Dept Med, Baltimore, MD 21287 USA
[2] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA
关键词
editorials; antioxidants; nitric oxide; cardiovascular diseases; kidney;
D O I
10.1161/01.CIR.0000066420.36123.35
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1951 / 1953
页数:3
相关论文
共 23 条
[1]   Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging [J].
Anker, SD ;
Doehner, W ;
Rauchhaus, M ;
Sharma, R ;
Francis, D ;
Knosalla, C ;
Davos, CH ;
Cicoira, M ;
Shamim, W ;
Kemp, M ;
Segal, R ;
Osterziel, KJ ;
Leyva, F ;
Hetzer, R ;
Ponikowski, P ;
Coats, AJS .
CIRCULATION, 2003, 107 (15) :1991-1997
[2]  
[Anonymous], 2000, BRIT J CLIN PHARMACO
[3]   Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms [J].
Barouch, LA ;
Harrison, RW ;
Skaf, MW ;
Rosas, GO ;
Cappola, TP ;
Kobeissi, ZA ;
Hobai, IA ;
Lemmon, CA ;
Burnett, AL ;
O'Rourke, B ;
Rodriguez, ER ;
Huang, PL ;
Lima, JAC ;
Berkowitz, DE ;
Hare, JM .
NATURE, 2002, 416 (6878) :337-340
[4]   Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy [J].
Cappola, TP ;
Kass, DA ;
Nelson, GS ;
Berger, RD ;
Rosas, GO ;
Kobeissi, ZA ;
Marbán, E ;
Hare, JM .
CIRCULATION, 2001, 104 (20) :2407-2411
[5]   Enhanced expression and activity of xanthine oxidoreductase in the failing heart [J].
de Jong, JW ;
Schoemaker, RG ;
de Jonge, R ;
Bernocchi, P ;
Keijzer, E ;
Harrison, R ;
Sharma, HS ;
Ceconi, C .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (11) :2083-2089
[6]   XANTHINE OXIDOREDUCTASE ACTIVITY IN PERFUSED HEARTS OF VARIOUS SPECIES, INCLUDING HUMANS [J].
DEJONG, JW ;
VANDERMEER, P ;
NIEUKOOP, AS ;
HUIZER, T ;
STROEVE, RJ ;
BOS, E .
CIRCULATION RESEARCH, 1990, 67 (03) :770-773
[7]   Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies [J].
Doehner, W ;
Schoene, N ;
Rauchhaus, M ;
Leyva-Leon, F ;
Pavitt, DV ;
Reaveley, DA ;
Schuler, G ;
Coats, AJS ;
Anker, SD ;
Hambrecht, R .
CIRCULATION, 2002, 105 (22) :2619-2624
[8]   Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure [J].
Ekelund, UEG ;
Harrison, RW ;
Shokek, O ;
Thakkar, RN ;
Tunin, RS ;
Senzaki, H ;
Kass, DA ;
Marbán, E ;
Hare, JM .
CIRCULATION RESEARCH, 1999, 85 (05) :437-445
[9]   Allopurinol improves endothelial dysfunction in chronic heart failure [J].
Farquharson, CA ;
Butler, R ;
Hill, A ;
Belch, JJF ;
Struthers, AD .
CIRCULATION, 2002, 106 (02) :221-226
[10]   Peroxidase properties of extracellular superoxide dismutase - Role of uric acid in modulating in vivo activity [J].
Hink, HU ;
Santanam, N ;
Dikalov, S ;
McCann, L ;
Nguyen, AD ;
Parthasarathy, S ;
Harrison, DG ;
Fukai, T .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (09) :1402-1408